People · Operator
Named in public records as an officer, director or promoter · active 2017–2021 · Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Direct Vet Marketing, Inc. | — | Other | Series D+ | $292.6M | $3.9B | 2017 |
| Blue Rabbit Ventures, Inc. | — | Pharmaceuticals | Series A | $28.2M | $219.6M | 2021 |
Benjamin J. Shaw at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Benjamin J. Shaw on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kevin Bitterman | 1 | 15 |
| DAVID SHAW | 1 | 12 |
| TERRANCE G. MCGUIRE | 1 | 7 |
| Philip J. Ferneau | 1 | 6 |
| Philip Ferneau | 1 | 6 |
| DAVID E. SHAW | 1 | 5 |
| Sarah Kim | 1 | 4 |
| Edward McNamara | 1 | 4 |
| Yumin Choi | 1 | 4 |
| Edward L. Cahill | 1 | 4 |
| Benjamin Shaw | 1 | 3 |
| Ravi Sachdev | 1 | 2 |
| Sean J. Carney | 1 | 1 |
| Edward J. McNamara | 1 | 1 |
| Terrence J. McGuire | 1 | 1 |
| Betsy J. Atkins | 1 | 1 |
| Ravi Sadchev | 1 | 1 |
| Sara Kim | 1 | 1 |
| Paul Bergkamp | 1 | 1 |
| Kerry Muse | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.